HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gabriele Siegert Selected Research

Group II Phospholipases A2

10/2013Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers.
4/2005Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells.
11/2004Glycogen synthase kinase-3beta negatively regulates group IIA phospholipase A2 expression in human aortic smooth muscle and HepG2 hepatoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gabriele Siegert Research Topics

Disease

13Neoplasms (Cancer)
01/2019 - 03/2008
10Inflammation (Inflammations)
06/2016 - 03/2006
6Prostatic Neoplasms (Prostate Cancer)
04/2014 - 02/2011
5Carcinogenesis
06/2016 - 02/2011
4Pheochromocytoma
11/2014 - 07/2012
4Paraganglioma (Paragangliomas)
11/2014 - 07/2012
3Hepatocellular Carcinoma (Hepatoma)
04/2014 - 11/2004
3Venous Thrombosis (Deep-Vein Thrombosis)
12/2003 - 01/2003
2Breast Neoplasms (Breast Cancer)
06/2016 - 12/2015
2Infections
10/2014 - 03/2014
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
12/2013 - 06/2012
2Neoplasm Metastasis (Metastasis)
09/2012 - 07/2012
2Thrombosis (Thrombus)
12/2003 - 01/2003
1Membranous Glomerulonephritis (Membranous Nephropathy)
01/2019
1Ischemic Stroke
02/2016
1Hypertension (High Blood Pressure)
01/2016
1Vasculitis (Vasculitides)
12/2015
1Venous Thromboembolism
08/2015
1Carotid Artery Diseases
02/2015
1Hyperaldosteronism (Conn Syndrome)
01/2015
1Fatty Liver
10/2014
1Obesity
10/2014
1Glucose Intolerance
10/2014
1Parkinson Disease (Parkinson's Disease)
01/2014
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2012
1Carcinoma (Carcinomatosis)
09/2012
1Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita)
08/2012
1Thrombocytopenia (Thrombopenia)
08/2012
1Subacute Combined Degeneration
03/2011
1Peripheral Nervous System Diseases (PNS Diseases)
03/2011

Drug/Important Bio-Agent (IBA)

6EnzymesIBA
01/2019 - 03/2006
4Secretory Phospholipases A2IBA
06/2016 - 03/2006
4NormetanephrineIBA
01/2014 - 07/2012
4Biomarkers (Surrogate Marker)IBA
12/2013 - 06/2012
4Phospholipases (Phospholipase)IBA
10/2013 - 01/2008
3Phospholipase A2 ReceptorsIBA
01/2019 - 12/2012
3CatecholaminesIBA
11/2014 - 03/2013
3C-Reactive ProteinIBA
03/2014 - 06/2012
3Dopamine (Intropin)FDA LinkGeneric
01/2014 - 07/2012
3AntigensIBA
12/2013 - 12/2003
3Group II Phospholipases A2IBA
10/2013 - 11/2004
2Vitamin KFDA Link
02/2016 - 08/2015
2SteroidsIBA
01/2015 - 11/2014
23-methoxytyramine (methoxytyramine)IBA
01/2014 - 07/2012
2MetanephrineIBA
01/2014 - 03/2013
2Norepinephrine (Noradrenaline)FDA LinkGeneric
03/2013 - 07/2012
2Endothelial Protein C ReceptorIBA
02/2011 - 09/2009
2Proteins (Proteins, Gene)FDA Link
09/2009 - 03/2008
2Factor V (Coagulation Factor V)IBA
12/2003 - 01/2003
1Phospholipases A2 (Phospholipase A2)IBA
01/2019
1LipidsIBA
01/2019
1AutoantibodiesIBA
01/2019
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2019
1Histone Deacetylase InhibitorsIBA
06/2016
1Group V Phospholipases A2IBA
06/2016
1trichostatin A (A 300)IBA
06/2016
1DNA (Deoxyribonucleic Acid)IBA
06/2016
1Histones (Histone)IBA
06/2016
1N(4)-oleylcytosine arabinosideIBA
02/2016
1AnticoagulantsIBA
02/2016
1Antihypertensive Agents (Antihypertensives)IBA
01/2016
1MicroRNAs (MicroRNA)IBA
12/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2015
1X-Box Binding Protein 1IBA
12/2015
1Transcription Factors (Transcription Factor)IBA
12/2015
1fibrin fragment D (D-dimer)IBA
08/2015
1Uric Acid (Urate)IBA
02/2015
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2015
1AldosteroneIBA
01/2015
1Myc associated factor XIBA
11/2014
1P-SelectinIBA
10/2014
1Glycoproteins (Glycoprotein)IBA
10/2014
1Insulin (Novolin)FDA Link
10/2014
1B7 AntigensIBA
10/2014
1ChemokinesIBA
10/2014
1AntioxidantsIBA
04/2014
1ImmunosorbentsIBA
04/2014
1FlavonoidsIBA
04/2014
1Silybin (Lagosa)IBA
04/2014
1CytokinesIBA
04/2014
1Protein Isoforms (Isoforms)IBA
04/2014
1Levodopa (L Dopa)FDA LinkGeneric
01/2014
1von Willebrand FactorIBA
10/2013
1Fibrinogen (Factor I)FDA Link
10/2013
1Factor VIII (Coagulation Factor VIII)IBA
10/2013
1AntithrombinsIBA
10/2013
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2013
1Plasminogen Activator Inhibitor 1IBA
06/2013
1Messenger RNA (mRNA)IBA
06/2013
1Plasminogen Activators (Plasminogen Activator)IBA
06/2013
1Dexamethasone (Maxidex)FDA LinkGeneric
02/2013
1Epinephrine (Adrenaline)FDA LinkGeneric
02/2013
1Azacitidine (5 Azacytidine)FDA Link
12/2012
1MethyltransferasesIBA
12/2012
1ThrombomodulinIBA
09/2012
1eltrombopagFDA Link
08/2012
1DiamondIBA
08/2012
1Prostate-Specific Antigen (Semenogelase)IBA
06/2012

Therapy/Procedure

4Therapeutics
08/2015 - 03/2006
1Thrombolytic Therapy
02/2016